SpaceX IPO Prospectus Expected to be Released Next Week
On May 15, according to CNBC, sources indicate that SpaceX plans to publicly disclose its IPO prospectus as early as next week. SpaceX aims to begin its roadshow on June 8 to formally introduce the transaction to investors. According to regulations, the relevant documents must be made public at least 15 calendar days before the roadshow starts, but SpaceX and its advisors hope to release them earlier to give investors more time to digest the financial data. Following SpaceX's merger with Elon Musk's AI company xAI in February, this IPO is expected to become the largest in history. The valuation of the merged entity has reached $1.25 trillion. Previous reports indicated that the company aims to raise between $70 billion and $75 billion in its IPO, which is more than double the record set by Saudi Aramco's IPO in 2019. Since there has never been such a large-scale IPO stock sale before, SpaceX's advisory team is seeking special sales channels, particularly targeting retail investors outside the U.S. who they believe will hold shares for a longer period, including engaging with brokers in countries like the UK, Japan, and Canada to secure allocation for their clients.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
London Gold and Silver Vault Data for September 2026
Bristol-Myers Squibb (BMY.US) rises in pre-market trading! Two experimental drugs report positive results in Phase 3 clinical trials, diversifying and accelerating the pipeline
Bristol Myers Squibb's two experimental drugs, used to treat a rare endocrine cancer and a deadly lung disease, have achieved success in Phase III clinical trials, injecting momentum into the pharmaceutical company’s new product pipeline.
